ALPINE IMMUNE SCIENCES, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
ALPINE IMMUNE SCIENCES, INC. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $166.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-02-13
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was $63.00K, a 1.61% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was $11.00K.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-12-31 was $62.00K, a 99.79% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-09-30 was -$2.10M, a 151.47% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $166.00K, a 99.79% decline from fiscal 2015.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $78.83M, a 91.50% increase from fiscal 2014.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $41.17M, a 280.78% increase from fiscal 2013.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $10.81M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | $74.00K derived: sum of 2 quarters · filed 2017-02-13 | $166.00K 10-K · filed 2017-02-13 | |
| 2016-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $103.00K 10-Q · filed 2016-11-07 | ||
| 2016-06-30 | $92.00K 10-Q · filed 2016-08-02 | |||
| 2015-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$2.04M derived: sum of 2 quarters · filed 2017-02-13 | $78.83M 10-K · filed 2017-02-13 | |
| 2015-09-30 | -$2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $78.77M 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $80.88M 10-Q · filed 2016-08-02 | |||
| 2014-12-31 | $29.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | $33.98M derived: sum of 2 quarters · filed 2017-02-13 | $41.17M 10-K · filed 2017-02-13 | |
| 2014-09-30 | $4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $11.27M 10-Q · filed 2015-11-03 | ||
| 2014-06-30 | $7.18M 10-Q · filed 2015-08-04 | |||
| 2013-12-31 | $10.81M 10-K · filed 2016-03-08 |